Treatments Given to Patients with NENs (n = 97) During Follow-up
| Treatment after PET/CT | n (%) |
|---|---|
| Somatostatin analog | 78 (80%) |
| Peptide receptor radionuclide therapy | 31 (32%) |
| Capecitabine/5-fluorouracil | 13 (13%) |
| Everolimus or sunitinib | 12 (12%) |
| Surgery | 11 (11%) |
| Temozolomide | 9 (9%) |
| Liver radiofrequency ablation or embolization | 9 (9%) |
| External radiation therapy | 7 (7%) |
| Etoposide ± carboplatin | 5 (5%) |
| Interferon | 5 (5%) |
| Streptozotocin | 3 (3%) |
| Docetaxel | 3 (3%) |